Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal intelligence from Strategic Transactions.
AstraZeneca PLC is selling the US rights to a portfolio of anesthetics to Aspen Pharmacare Holdings Ltd. in...








